Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Podocytes | 5 | 2022 | 408 | 2.540 |
Why?
|
Lupus Nephritis | 6 | 2022 | 328 | 2.340 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 6 | 2023 | 82 | 1.320 |
Why?
|
Acute Lung Injury | 3 | 2013 | 381 | 0.830 |
Why?
|
Acute Kidney Injury | 8 | 2020 | 1890 | 0.630 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1694 | 0.450 |
Why?
|
Interleukin-6 | 5 | 2017 | 3215 | 0.450 |
Why?
|
Immunoglobulin G | 2 | 2021 | 4482 | 0.450 |
Why?
|
Kidney Transplantation | 1 | 2020 | 4139 | 0.280 |
Why?
|
Glomerulosclerosis, Focal Segmental | 2 | 2018 | 331 | 0.270 |
Why?
|
Blood Urea Nitrogen | 2 | 2013 | 198 | 0.250 |
Why?
|
Pneumonia | 2 | 2013 | 2094 | 0.220 |
Why?
|
Sirtuin 2 | 1 | 2022 | 116 | 0.220 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2013 | 4476 | 0.210 |
Why?
|
Complement System Proteins | 2 | 2022 | 835 | 0.210 |
Why?
|
Fucose | 1 | 2021 | 117 | 0.200 |
Why?
|
Endotoxins | 2 | 2013 | 561 | 0.200 |
Why?
|
Arthritis, Experimental | 1 | 2023 | 292 | 0.200 |
Why?
|
Galactose | 1 | 2021 | 309 | 0.190 |
Why?
|
Interleukin-23 | 1 | 2021 | 183 | 0.190 |
Why?
|
Sepsis | 1 | 2013 | 2474 | 0.190 |
Why?
|
Interleukin-10 | 2 | 2017 | 1214 | 0.190 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2022 | 2109 | 0.180 |
Why?
|
Th17 Cells | 3 | 2023 | 752 | 0.180 |
Why?
|
Cytokines | 4 | 2023 | 7225 | 0.180 |
Why?
|
Kidney Tubules | 1 | 2021 | 494 | 0.180 |
Why?
|
Mesangial Cells | 1 | 2018 | 27 | 0.180 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2020 | 504 | 0.180 |
Why?
|
Creatinine | 2 | 2013 | 1902 | 0.160 |
Why?
|
Mucin-1 | 1 | 2021 | 534 | 0.150 |
Why?
|
Peroxidase | 3 | 2017 | 624 | 0.150 |
Why?
|
Calcium Signaling | 1 | 2021 | 764 | 0.150 |
Why?
|
Kidney | 2 | 2022 | 6903 | 0.150 |
Why?
|
Antibodies, Monoclonal | 1 | 2013 | 9584 | 0.150 |
Why?
|
Peritoneal Dialysis | 1 | 2017 | 163 | 0.150 |
Why?
|
Interleukin-17 | 1 | 2022 | 889 | 0.140 |
Why?
|
Osteogenesis | 1 | 2023 | 1289 | 0.140 |
Why?
|
Kidney Glomerulus | 1 | 2018 | 691 | 0.140 |
Why?
|
Rhabdomyolysis | 1 | 2015 | 154 | 0.130 |
Why?
|
Androstenes | 1 | 2015 | 170 | 0.130 |
Why?
|
Mice | 12 | 2023 | 80995 | 0.130 |
Why?
|
Lipocalins | 1 | 2013 | 175 | 0.120 |
Why?
|
Lung Injury | 1 | 2017 | 402 | 0.110 |
Why?
|
Chemokine CXCL1 | 1 | 2012 | 106 | 0.110 |
Why?
|
Acute-Phase Proteins | 1 | 2013 | 273 | 0.110 |
Why?
|
NF-kappa B | 1 | 2021 | 2579 | 0.110 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2017 | 616 | 0.110 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2013 | 852 | 0.100 |
Why?
|
Calcium | 2 | 2023 | 5818 | 0.100 |
Why?
|
Mice, Inbred MRL lpr | 2 | 2022 | 169 | 0.100 |
Why?
|
Models, Animal | 1 | 2017 | 2219 | 0.100 |
Why?
|
Epithelial Cells | 1 | 2022 | 3687 | 0.090 |
Why?
|
Mice, Inbred C57BL | 5 | 2017 | 22936 | 0.090 |
Why?
|
Oncogene Proteins | 1 | 2013 | 764 | 0.090 |
Why?
|
Animals | 12 | 2023 | 170726 | 0.090 |
Why?
|
Cell Line | 2 | 2021 | 16680 | 0.080 |
Why?
|
Trachea | 1 | 2013 | 1085 | 0.080 |
Why?
|
Lung | 2 | 2017 | 9765 | 0.070 |
Why?
|
Glomerular Filtration Rate | 1 | 2013 | 2101 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2018 | 3050 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2017 | 4375 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2013 | 6531 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2021 | 8093 | 0.060 |
Why?
|
Interleukin-2 | 2 | 2022 | 1932 | 0.060 |
Why?
|
Humans | 13 | 2022 | 715124 | 0.060 |
Why?
|
Arginase | 1 | 2021 | 79 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2020 | 24645 | 0.050 |
Why?
|
Receptors, Interleukin | 1 | 2021 | 246 | 0.050 |
Why?
|
Complement Activation | 1 | 2022 | 466 | 0.050 |
Why?
|
Lectins | 1 | 2022 | 559 | 0.050 |
Why?
|
Mice, Knockout | 3 | 2021 | 15260 | 0.040 |
Why?
|
Male | 7 | 2021 | 351081 | 0.040 |
Why?
|
Niacinamide | 1 | 2020 | 434 | 0.040 |
Why?
|
Cell Line, Transformed | 1 | 2018 | 986 | 0.040 |
Why?
|
Nephrectomy | 2 | 2012 | 1001 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2021 | 1892 | 0.040 |
Why?
|
Proteinuria | 1 | 2018 | 623 | 0.040 |
Why?
|
Signal Transduction | 1 | 2018 | 23973 | 0.030 |
Why?
|
Young Adult | 1 | 2021 | 56155 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11317 | 0.030 |
Why?
|
Aged | 3 | 2021 | 162674 | 0.030 |
Why?
|
Adolescent | 1 | 2021 | 84999 | 0.030 |
Why?
|
Capillary Leak Syndrome | 1 | 2012 | 32 | 0.030 |
Why?
|
Receptors, Interleukin-8B | 1 | 2012 | 65 | 0.030 |
Why?
|
Time Factors | 1 | 2013 | 41081 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2020 | 1742 | 0.030 |
Why?
|
Spleen | 1 | 2017 | 2476 | 0.020 |
Why?
|
Middle Aged | 2 | 2021 | 214871 | 0.020 |
Why?
|
Adult | 2 | 2021 | 212129 | 0.020 |
Why?
|
Neutrophil Infiltration | 1 | 2012 | 406 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6677 | 0.020 |
Why?
|
Female | 3 | 2021 | 377334 | 0.020 |
Why?
|
Up-Regulation | 1 | 2017 | 4353 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2862 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18345 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2023 | 11746 | 0.020 |
Why?
|
Antibodies | 1 | 2012 | 2445 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2017 | 4918 | 0.010 |
Why?
|
Ischemia | 1 | 2012 | 1939 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 12425 | 0.010 |
Why?
|
Macrophages | 1 | 2017 | 5805 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10082 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3130 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 51181 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 58505 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 70704 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 72255 | 0.010 |
Why?
|
Concepts
(107)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_